Dividend Dispatch — Header
| 💰 |
|
Dividend Dispatch
|
|
Income is everywhere. I find it.
|
|
|
|
Thursday, September 17, 2026
·
6 min read
|
|
|
|
Dividend Dispatch — Today's Theme
|
Today's Theme
|
|
The small yield that becomes the big yield
|
|
I was going through my growth screen this morning — sorting S&P 500 names by five-year dividend growth rate — and MSCI jumped out at me. Not because of what it pays today. At 1.48%, it looks like nothing. But MSCI has grown that dividend roughly 20% a year for five straight years. The payout ratio is only 42%. I did the math: if the growth continues, your 1.48% yield today becomes a 9%+ yield on cost in a decade. Today I've got two names like that in Growth Stars — MSCI and ADP. Then Johnson & Johnson for the safety shelf, and a warning about Pfizer's tempting 6.2% yield.
|
|
|
|
Is Your Retirement One Ruling From Seizure?
A recent DOJ court argument claims your money isn't legally yours — opening the door to frozen accounts and confiscated retirement savings. History shows that when governments run out of money, they take it from savers. Learn the 3 moves smart investors are making right now to shield their savings with physical gold before it's too late.
Dividend Dispatch — Section 1a
|
|
Dividend Growth Stars
Fast-rising income builders
|
|
MSCIThe index giant nobody thinks of as a dividend stock
|
MSCI builds the indexes that trillions of dollars track. If you've ever heard someone say "emerging markets are up," they're usually talking about an MSCI index. They also sell analytics tools and ESG ratings. Over 95% of their revenue is recurring — it keeps coming whether markets are up or down.
The yield is 1.48%. I know that doesn't scream income. But here's what got me excited: MSCI has grown its dividend roughly 20% a year over the last five years. And the payout ratio — the share of earnings going to dividends — is only 42%. That's a company keeping most of its profits and still raising the dividend 20%.
I love teaching this concept. It's called "yield on cost." You invest $10,000 today and get $148 a year. But if the dividend keeps growing 20% annually, that same $10,000 is paying you about $916 a year in a decade. Your 1.48% yield becomes 9%+ on your original investment — without you lifting a finger.
The risk: MSCI trades around $550 a share. You're paying a premium for that growth. If subscription revenue slows or competition from S&P Global heats up, the growth rate could come down. This is a hold-for-the-long-haul name, not a quick win.
|
|
Yield: 1.48%
|
$10K invested = $148/yr
|
Paid: Quarterly
|
|
|
|
|
|
Marc Chaikin Issues the "Strangest" Prediction of His 60-Year Career
Wall Street legend Marc Chaikin has advised billionaires like George Soros, Steve Cohen and D.E. Shaw. He predicted the 2020 Covid Crash... the 2022 bear... and the 2025 tariff sell-off, too. But he's never made a prediction like the one he just issued.
According to Chaikin, a $248T "White Swan" event is about to overturn the AI industry... and the global order, too. It involves a strange new technology called "micro clusters." These miniaturized data centers will render current AI tech obsolete when it comes to major breakthroughs – including models from SpaceX, Google, Anthropic and OpenAI. And they could send shares of one obscure company soaring starting Sept. 29th. Go here for Marc's full prediction and the name and ticker of the stock, for free.
Dividend Dispatch — Section 1b
|
ADP51 straight years of raises — and it just posted 17% earnings growth
|
ADP processes payroll. Every two weeks, millions of workers across America get their paychecks — and a huge number of those flow through ADP's systems. They also handle HR, tax filing, and benefits administration. It's the kind of business that doesn't make headlines, but it never goes away.
The dividend has been raised 51 consecutive years. That's Dividend King territory — a company that's raised through every recession since 1975. But I'm putting ADP in Growth Stars because the speed of the raises is the story: 12.9% annualized over five years.
The latest quarter backed that up. Revenue grew 7% to $5.47 billion. Adjusted earnings jumped from $2.26 to $2.64 per share — that's nearly 17% EPS growth. When earnings grow faster than the dividend, you know there's headroom for more raises. The payout ratio sits around 62% of earnings — comfortable, not stretched.
The risk: ADP's business is tied to employment. In a recession, fewer people on payroll means fewer paychecks to process. But 51 years of raises through oil crises, dot-com crashes, and a pandemic tell me they know how to manage through downturns. ADP went ex-dividend September 11 — your $1.70 per share arrives October 1.
|
|
Yield: 2.49%
|
$10K invested = $249/yr
|
Paid: Quarterly
|
|
|
|
|
|
A new type of AI called "Accelerated AI" is about to take the world by storm…
And stocks connected to it are already breaking out: 133%… 210%… and even 320% or more just in the last few months.
But it's just getting started…
If you want to learn more about "Accelerated AI" – and get name and ticker of the #1 pick to play this opportunity…
Dividend Dispatch — Main Rest
|
|
Safety & Watchlist
Reliable picks + red flags
|
|
Safe Pick
|
|
JNJ64 consecutive years of raises. That's the whole story.
|
Johnson & Johnson raised its dividend 3.1% in April — to $1.34 per quarter, or $5.36 a year. That was the 64th consecutive annual increase. Sixty-four. That stretches back to 1963. Kennedy was president.
After spinning off its consumer health business (Kenvue), JNJ is now a focused pharmaceutical and medical device company. The payout ratio — the share of earnings paid out as dividends — sits around 49%. EPS guidance for 2026 is $10.96 to $11.11 (adjusted), and margins are improving even as the company absorbs roughly $500 million in tariff costs this year.
The yield is 1.95%. That's $195 a year on $10,000, paid quarterly like clockwork. Not flashy. Not trying to be. JNJ is presenting at the Deutsche Bank Healthcare Summit today — September 17 — and I'll be watching for any pipeline updates. When I think "safe," JNJ is the first name I reach for.
|
|
Yield: 1.95%
|
$10K invested = $195/yr
|
Paid: Quarterly
|
|
|
|
Watchlist
|
|
PFE6.2% yield, 351 quarterly payments — but the math is getting tight
|
I've been getting emails about Pfizer. The yield is 6.21% — that's $621 a year on $10,000, paid quarterly. And Pfizer has made 351 consecutive quarterly dividend payments. That's nearly 88 years of unbroken checks.
So why is this on my watchlist and not in my buy pile? The payout ratio. On a GAAP basis — meaning using reported earnings — Pfizer paid out 126.5% of its earnings as dividends in fiscal 2025. Even on a free-cash-flow basis, the ratio was 107.7%. That's a company spending more than every dollar of cash it generates on the dividend, and then borrowing to cover the rest.
The bigger issue is the patent cliff. Several of Pfizer's top-selling drugs lose patent protection between 2027 and 2028. When that happens, generic competition arrives and revenue can drop fast. Management says the pipeline will fill the gap, but the gap is measured in billions and debt stands at $63.2 billion.
I'm not saying sell. I'm saying wait. If PFE navigates the cliff and maintains coverage, this could be a great entry. But right now, I want to see another quarter or two of data before I'd add shares.
|
|
Yield: 6.21%
|
$10K invested = $621/yr
|
Paid: Quarterly
|
|
|
|
|
|
The Extra Yield
This week's calendars, screens & answers
|
|
Don't miss this ex-date: Danaher (DHR) just declared its quarterly dividend on September 15 — $0.40 per share. The ex-dividend date is September 30. If you want this payment, you need to own shares by September 29.
|
|
ADP payday incoming: ADP went ex-dividend September 11. If you own shares, your $1.70 per share arrives October 1. That's $6.80 a year per share — and the 51st straight year they've raised it.
|
|
Someone asked me: "What's the difference between a Growth Star and a Dividend Aristocrat?" Velocity vs. longevity. An Aristocrat has raised for 25+ consecutive years — it's about the streak. A Growth Star might have a shorter streak, but the raises are bigger — 15%, 20% a year. MSCI has "only" 11 years of raises, but at 20% a year. ADP qualifies as both — 51 years and 12.9% annual growth. That's rare.
|
|
|
|
The Dispatch
|
|
Today was about growth — the kind you can't see on a yield screen. MSCI at 1.48% and ADP at 2.49% don't scream "income." But run those growth rates forward and both are on track to deliver 8%+ yields on cost within a decade. JNJ remains my favorite safe anchor at 64 straight years, and Pfizer stays on the watchlist until the patent cliff clears. Tomorrow's the weekly roundup — I'll pick the best idea from every section this week. See you then.
|
|
— Charlie
|
|
|
|